← Leaderboards
Mark Shuo Chen
Duke University
$154,560
Attributed
$154,560
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $41.6K · FY2016–19$50K$37.5K$25K$12.5K$0
'16
'17
'18
'19
Funding mix
By agency
NIH$154,560 · 1
By mechanism
F30$154,560 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Michael Barry Kastan$65,974,699
- John H Sampson$43,413,436
- Nelson J. Chao$27,968,804
- Scott M Palmer$46,531,610
- Walter J Koch$36,219,689
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroAdultHuman DiseaseHistologyBoneCancer BurdenApoptosisAdenovirusesCell LineBiological Adaptation To StressChromosomal RearrangementConnective TissueCrispr/Cas TechnologyDna DamageCancer PatientEngineeringFatty Acid Glycerol EstersCaringGenerationsGenesChimeric ProteinsGenome EditingGuide RnaIn Vivo
Grant awards (4)
Using CRISPR/Cas9 to dissect the role of FUS-CHOP in tumor response to radiation therapy$41,616
F30 · FY2019 · CA · contact PI
Using CRISPR/Cas9 to dissect the role of FUS-CHOP in tumor response to radiation therapy$38,124
F30 · FY2018 · CA · contact PI
Using CRISPR/Cas9 to dissect the role of FUS-CHOP in tumor response to radiation therapy$37,644
F30 · FY2017 · CA · contact PI
Using CRISPR/Cas9 to dissect the role of FUS-CHOP in tumor response to radiation therapy$37,176
F30 · FY2016 · CA · contact PI